Superdisintegrants Market Report and Forecast 2023-2031

The global superdisintegrants market value was USD 394.8 million in 2022, driven by the increasing regulatory guidelines and quality standards imposed by regulatory bodies across the globe. The market size is anticipated to grow at a CAGR of 7.3% during the forecast period of 2023-2031 to achieve a value of USD 741.2 million by 2031.

Superdisintegrants: Introduction

Superdisintegrants are pharmaceutical excipients used in the formulation of oral solid dosage forms to enhance disintegration and dissolution rates. They play a crucial role in the rapid disintegration of tablets or capsules in the gastrointestinal tract, facilitating drug release and absorption. Superdisintegrants aid in improving the bioavailability and therapeutic efficacy of orally administered drugs.

Key Trends in the Superdisintegrants Market

Some key trends involved in the superdisintegrants market are as follows:

• Growing Demand for Fast-Acting Formulations: The demand for fast-acting oral dosage forms has increased due to the need for immediate drug release and onset of action. Superdisintegrants offer an effective solution by promoting rapid disintegration, which is especially beneficial for drugs with a narrow absorption window or those requiring quick therapeutic effects
• Technological Advancements: Continuous research and development efforts have led to the development of new and improved superdisintegrant materials with enhanced performance characteristics. These advancements include the use of novel polymers, co-processed excipients, and surface modified particles, which offer better disintegration properties and compatibility with different drug formulations
• Growing Popularity of Orally Disintegrating Tablets (ODTs): Orally disintegrating tablets have gained popularity due to their convenience, ease of administration, and patient compliance. Superdisintegrants are key components in ODT formulations, as they facilitate rapid disintegration and provide a pleasant mouthfeel. The increasing demand for ODTs across various therapeutic areas has driven the market for superdisintegrants
• Increasing Focus on Pediatric and Geriatric Formulations: Pediatric and geriatric patients often face difficulties in swallowing conventional tablets or capsules. Superdisintegrants offer a solution by improving the disintegration and ease of administration of oral dosage forms in these patient populations. As the demand for age-specific formulations increases, the use of superdisintegrants in pediatric and geriatric medications is expected to grow

Superdisintegrants Market Segmentations

Market Breakup by Product Type

• Synthetic Superdisintegrants
• Natural Superdisintegrants

Market Breakup by Formulation Type

• Tablets
• Capsules
• Other

Market by Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Others

Market Breakup by Applications

• Pharmaceutical
• Nutraceuticals
• Others

Market Breakup by Region

North America

• United States of America
• Canada

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Asia Pacific

• China
• Japan
• India
• ASEAN
• Australia
• Others

Latin America

• Brazil
• Argentina
• Mexico
• Others

Middle East and Africa

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Superdisintegrants Market Scenario

The market for superdisintegrants is experiencing significant growth due to the increasing demand for fast-acting oral dosage forms and the need to enhance drug absorption and bioavailability. Superdisintegrants are widely used in the pharmaceutical industry to improve the disintegration and dissolution rates of oral solid dosage forms such as tablets and capsules.

The market is driven by several factors, including the growing prevalence of chronic diseases, the rising geriatric population, and the increasing focus on patient-centric healthcare. Patients and healthcare providers are seeking formulations that offer convenience, ease of administration, and rapid onset of action. Superdisintegrants play a vital role in meeting these requirements by enabling faster drug disintegration and dissolution, leading to enhanced therapeutic outcomes.

The market for superdisintegrants is also driven by regulatory guidelines and quality standards imposed by regulatory bodies. Manufacturers are required to comply with these guidelines to ensure the safety, quality, and efficacy of pharmaceutical products containing superdisintegrants. This focus on regulatory compliance and adherence to quality standards further drives the growth and adoption of superdisintegrants in the market.

Superdisintegrants Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Ashland Global Specialty Chemicals Inc
• Roquette Frères S.A
• FMC Corporation
• DFE Pharma GmbH and Co. KG
• DuPont de Nemours, Inc
• BASF SE
• J.M. Huber Corporation